Financial News
22nd Century Group, Inc - Common Stock (NQ: XXII )
3.190
+0.100
(+3.24%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
Press Releases about 22nd Century Group, Inc - Common Stock
22nd Century Applauds FDA Proposal to Mandate Reduced Nicotine Content in Cigarettes
December 12, 2024
Via Newsfile
![](https://ml.globenewswire.com/media/023c4053-1580-4559-8cc9-e3fdeb63a2cf/small/1-01-16x9-gvb-biopharma-kk-123911-1-png.png)
![](https://ml.globenewswire.com/media/023c4053-1580-4559-8cc9-e3fdeb63a2cf/small/1-01-16x9-gvb-biopharma-kk-123911-1-png.png)
![](https://ml.globenewswire.com/media/023c4053-1580-4559-8cc9-e3fdeb63a2cf/small/1-01-16x9-gvb-biopharma-kk-123911-1-png.png)
![](https://ml.globenewswire.com/media/023c4053-1580-4559-8cc9-e3fdeb63a2cf/small/1-01-16x9-gvb-biopharma-kk-123911-1-png.png)
![](https://ml.globenewswire.com/media/023c4053-1580-4559-8cc9-e3fdeb63a2cf/small/1-01-16x9-gvb-biopharma-kk-123911-1-png.png)
![](https://ml.globenewswire.com/media/023c4053-1580-4559-8cc9-e3fdeb63a2cf/small/1-01-16x9-gvb-biopharma-kk-123911-1-png.png)
22nd Century Group (XXII) Reports Third Quarter 2023 Financial Results
November 06, 2023
Via GlobeNewswire
![](https://ml.globenewswire.com/media/023c4053-1580-4559-8cc9-e3fdeb63a2cf/small/1-01-16x9-gvb-biopharma-kk-123911-1-png.png)
![](https://ml.globenewswire.com/media/023c4053-1580-4559-8cc9-e3fdeb63a2cf/small/1-01-16x9-gvb-biopharma-kk-123911-1-png.png)
![](https://ml.globenewswire.com/media/023c4053-1580-4559-8cc9-e3fdeb63a2cf/small/1-01-16x9-gvb-biopharma-kk-123911-1-png.png)
22nd Century Announces Pricing of $5.25 Million Public Offering
October 17, 2023
Via GlobeNewswire
![](https://ml.globenewswire.com/media/023c4053-1580-4559-8cc9-e3fdeb63a2cf/small/1-01-16x9-gvb-biopharma-kk-123911-1-png.png)
22nd Century Announces Proposed Public Offering
October 16, 2023
Via GlobeNewswire
![](https://ml.globenewswire.com/media/023c4053-1580-4559-8cc9-e3fdeb63a2cf/small/1-01-16x9-gvb-biopharma-kk-123911-1-png.png)
![](https://ml.globenewswire.com/media/023c4053-1580-4559-8cc9-e3fdeb63a2cf/small/1-01-16x9-gvb-biopharma-kk-123911-1-png.png)
22nd Century Group Initiates Strategic Alternatives Process for Its Tobacco Assets
September 05, 2023
Via GlobeNewswire
![](https://ml.globenewswire.com/media/023c4053-1580-4559-8cc9-e3fdeb63a2cf/small/1-01-16x9-gvb-biopharma-kk-123911-1-png.png)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/023c4053-1580-4559-8cc9-e3fdeb63a2cf/small/1-01-16x9-gvb-biopharma-kk-123911-1-png.png)
![](https://ml.globenewswire.com/media/023c4053-1580-4559-8cc9-e3fdeb63a2cf/small/1-01-16x9-gvb-biopharma-kk-123911-1-png.png)
![](https://ml.globenewswire.com/media/023c4053-1580-4559-8cc9-e3fdeb63a2cf/small/1-01-16x9-gvb-biopharma-kk-123911-1-png.png)
22nd Century Announces Executive Leadership Changes
July 24, 2023
Via GlobeNewswire
![](https://ml.globenewswire.com/media/023c4053-1580-4559-8cc9-e3fdeb63a2cf/small/1-01-16x9-gvb-biopharma-kk-123911-1-png.png)
![](https://ml.globenewswire.com/media/023c4053-1580-4559-8cc9-e3fdeb63a2cf/small/1-01-16x9-gvb-biopharma-kk-123911-1-png.png)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/023c4053-1580-4559-8cc9-e3fdeb63a2cf/small/1-01-16x9-gvb-biopharma-kk-123911-1-png.png)
![](https://ml.globenewswire.com/media/023c4053-1580-4559-8cc9-e3fdeb63a2cf/small/1-01-16x9-gvb-biopharma-kk-123911-1-png.png)
![](https://ml.globenewswire.com/media/023c4053-1580-4559-8cc9-e3fdeb63a2cf/small/1-01-16x9-gvb-biopharma-kk-123911-1-png.png)
![](https://ml.globenewswire.com/media/023c4053-1580-4559-8cc9-e3fdeb63a2cf/small/1-01-16x9-gvb-biopharma-kk-123911-1-png.png)
![](https://ml.globenewswire.com/media/404cd4b7-318c-4bbb-9410-d66b3cbcbd88/small/22nd-century-group-logo-jpg.jpg)
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.